Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients

Abstract

The established role of hypoxia-induced signaling in prostate cancer growth, metastasis, and response to treatment suggests that a method to image hypoxia in tumors could aid treatment decisions. Here, we present consumption and supply-based hypoxia (CSH) imaging, an approach that integrates images related to oxygen consumption and supply into a single image. This integration algorithm was developed in patients with prostate cancer receiving hypoxia marker pimonidazole prior to prostatectomy. We exploited the intravoxel incoherent motion (IVIM) signal in diagnostic diffusion-weighted (DW) magnetic resonance (MR) images to generate separate images of the apparent diffusion coefficient (ADC) and fractional blood volume (fBV). ADC and fBV correlated with cell density (CD) and blood vessel density (BVD) in histology and whole-mount sections from 35 patients, thus linking ADC to oxygen consumption and fBV to oxygen supply. Pixel-wise plots of ADC versus fBV were utilized to predict the hypoxia status of each pixel in a tumor and to visualize the predicted value in a single image. The hypoxic fraction (HF) of CSH images correlated strongly ( = 0.66; = 41) with pimonidazole immunoscore (HS); this relationship was validated in a second pimonidazole cohort ( = 0.54; = 54). We observed good agreement between CSH images and pimonidazole staining in whole-mount sections. HF correlated with tumor stage and lymph node status, consistent with findings for HS Moreover, CSH imaging could be applied on histologic CD and BVD images, demonstrating transferability to a histopathology assay. Thus, CSH represents a robust approach for hypoxia imaging in prostate cancer that could easily be translated into clinical practice. These findings present a novel imaging strategy that indirectly measures tumor hypoxia and has potential application in a wide variety of solid tumors and other imaging modalities. http://cancerres.aacrjournals.org/content/canres/78/16/4774/F1.large.jpg .

Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?

“…Among different subtypes of MRI and MRS techniques, such as dynamic contrast-enhanced (DCE), blood oxygen level dependent (BOLD), diffusion-weighted (DW) MRI, 31 P-MRS, and 1 H-MRS, DCE–MRI clearly demonstrates the correlation of hypoxic state in tumors with radiotherapy outcome in patients with cervical cancer [62,63,64]. Recently, by exploiting the intravoxel incoherent motion signal in DW-MRI, both oxygen consumption and supply can be assessed, and the generated images on hypoxic tumors could help identify aggressive disease in prostate cancer [65]. Tumor hypoxia can also be inferred from the expression of various endogenous proteins, such as HIF-1α, glucose transporters-1 or -3, vascular endothelial growth factor-A, and carbonic anhydrase-9 [66,67,68,69,70,71].…”

Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapy

“…An approximation of the original IVIM model is provided by the so-called simplified IVIM model [22] , [23] , [24] . As in tissue the condition is usually met, the first term of Eq.…”

“…A thorough evaluation of the signal decay curves is required to select optimal b -values for a particular model and anatomical site beforehand, for example by analyzing the goodness of fit when including different b -value combinations. An approach of performing such an evaluation is provided in [24] in the context of prostate cancer.…”

Adapting training for medical physicists to match future trends in radiation oncology

“…Depending on the anatomical position, 4D-imaging to account for intra-fraction motion may be required to provide the technology for online adaptive image-guided radiation therapy [12][13][14][15]. Finally, a number of studies have identified multiparametric functional imaging as an ideal tool to assess dedicated molecular biomarkers containing information about biological characteristics or response prognosis with respect to outcome [16][17][18][19].…”